Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)
1 clinical trials · Condition
◉ Watch Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NCT05014815) | BeiGene | 2021-11-16 |
Track Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.